A Secure Online Service from Utah.gov

Utah.gov

Public Notice Website

Division of Archives and Records Service

State Medicaid P&T Committee Meeting - Revision 3

This is a Notice Revision

You are currently viewing a revision of a notice. This is a previous copy of a notice that has been published more recently. To view the current version of this notice, click here.

Please Note: Only the files that were associated to this version are included in the Download Attachments section. If that section does not display, all attachments were removed from this version of the notice.

General Information

Government Type
State Agency
Entity
Department of Health and Human Services (DHHS)
Public Body
Pharmacy and Therapeutics Committee

Notice Information

Notice Title
State Medicaid P&T Committee Meeting
Notice Tags
Medicaid, Pharmacies
Notice Type(s)
Meeting
Event Start Date & Time
May 15, 2025 07:00 AM
Event End Date & Time
May 15, 2025 08:45 AM
Event Deadline Date & Time
05/15/25 08:45 AM
Description/Agenda
Pharmacy & Therapeutics Committee Meeting Agenda Thursday, May 15, 2025 7:00 a.m. to 8:45 a.m. Google Meet joining information Video call link: mee.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the P&T Committee may contact Ngan Huynh at (nganhuynh@utah.gov) before the meeting or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Susan Siegfried, MD, Chair a) Announce Quorum 2) Welcome and Introductions - Susan Siegfried, MD, Chair a) Review and Approval of Minutes b) Housekeeping 3) DUR Board Update - Luis Moreno, PharmD 4) Annual Open Public Meeting Training - Tony Patterson, Assistant Attorney General 5) Review a) ALK, MET, AND RET Selective Inhibitors For Approved Oncologic Disorders - Valerie Gonzales, PharmD i) alectinib (ALECENSA), brigatinib (ALUNBRIG), capmatinib (TABRECTA), certanib (ZYKADIA), crizotinib (XALKORI), ensartib (ENSACOVETM), lorlatinib (LORBRENA), praalsetinib (GAVRETO), selpercatinib (RETEVMO), tepotinib (TEPMETKO) b) Committee Discussion/Questions c) Committee Action
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Bryan Larson at 801-538-6149.
Notice of Electronic or Telephone Participation
N/A

Meeting Information

Meeting Location
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps
Contact Name
Ngan Huynh
Contact Email
nganhuynh@utah.gov
Contact Phone
801-538-6155

Notice Posting Details

Notice Posted On
May 07, 2025 10:36 AM
Notice Last Edited On
May 07, 2025 10:59 AM
Deadline Date
May 15, 2025 08:45 AM

Back to Current Notice